Schafer Klaus

Altimmune, Inc. · Director

Schafer Klaus is listed in filings as Director at Altimmune, Inc.. This profile follows SEC Form 4 activity through May 1, 2026, including 3 public disclosures. Recent filings connect the profile to Altimmune, Inc. (ALT). The current snapshot covers public activity from Sep 30, 2024 to May 1, 2026. Reported amounts are shown as $137.6K to $237.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceCurrent Price
No direct insider buys or sells are available yet.